ClinicalTrials.gov
public full text
Public Domain
Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients
The effect of Chromium to improve glucose levels in Alzheimer Disease (AD) is controversial. The hypothesis of the study is to evaluate the effect of supplementing the AD individuals with Chromium combined with exercise and assessing the effect of the supplementation on glucose metabolism.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antioxidant Treatment of Type 2 Diabetes#1261421
- Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm#947744
- Metformin Effect on Brain Function in Insulin Resistant Elderly People#184798
- The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia#948865
- BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)#1243775
Record · ID 1339712
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive